• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    77,651
    Total Members
    3,093
    Most Online
    Kitty11
    Newest Member
    Kitty11
    Joined
  • 0

    Can Production Cuts Stop Plummeting Wheat Prices?


    Jefferson Adams


    • Italy, Canada's second largest buyer of durum wheat in 2016, is planning to introduce rules in early 2018 that could further reduce imports.


    Image Caption: Can anything help falling global wheat prices? Photo: CC--Martin Pettitt

    Celiac.com 10/24/2017 - Global wheat prices are plummeting in the wake of massive overstocks and anemic consumption. The problem is serious enough that Canada, the world's top producer of durum wheat, has cut its production nearly in half, to a six-year low.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    Even those drastic measures have had failed to raise prices, which are down about 30 percent from 2016.

    Worse still, experts are projecting a continuing decline in demand over the next year. Italy, Canada's second largest buyer of durum wheat in 2016, is planning to introduce rules in early 2018 that could further reduce imports.

    This comes at a time when consumers are buying less wheat products, as more and more people are adopting gluten-free, and low-carbohydrate diets.

    Italy is not the only problem for wheat growers, and durum is not the only variety to be hit by the reduction in demand.

    Weak demand overall will drive total global wheat stockpiles up to a record 263.4 million metric tons in 2017, according analysts surveyed by Bloomberg.

    Those predictions exceed estimates made by the U.S. Department of Agriculture, and the agency has already taken steps to revise its earlier estimate.

    According to Neil Townsend, a senior analyst at FarmLink in Winnipeg, Manitoba, Italy's plan is “just another nail in the coffin” to industry efforts to incrementally grow demand.

    After slowly bouncing back from the Atkins diet craze, the wheat industry is now “kind of getting gnawed away by the gluten thing. There's just no growth,” said Townsend.

    Source:

    0


    User Feedback

    Recommended Comments

    The question is different, durum wheat of Canada it has the presence of gliphosate !

    Share this comment


    Link to comment
    Share on other sites
    Guest Jefferson

    Posted

    What is your evidence for that claim?

    Share this comment


    Link to comment
    Share on other sites


    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Ads by Google:

  • About Me

    Jefferson Adams is a freelance writer living in San Francisco. He has covered Health News for Examiner.com, and provided health and medical content for Sharecare.com. His work has appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate, among others.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   13 Members, 0 Anonymous, 603 Guests (See full list)

  • Related Articles

    Jefferson Adams
    Celiac.com 10/18/2016 - Whole grains, including gluten-free grains, have never been more popular, but as their fortunes grow as a whole, that of wheat is diminishing.
    The whole grains category includes both gluten-free grains, such as quinoa and other ancient grains, and gluten grains, such as barley, rye and triticale, but wheat products have never been less popular, and continue their downward sales slide.
    This year, 1,282 new products have registered for the Whole Grain Stamp so far, a pace set to meet or beat last year's record of 2,122 new products; up from 1,666 in 2014 and 1,622 in 2013, according to Cynthia Harriman, director of food and nutrition strategies at the Whole Grains Council. More than half of new products with the Whole Grain Stamp had a gluten-free first ingredient last year, an increase over 33% in 2007 to 2009, according to Harriman. However, even as scientists question the claimed benefits of gluten-free foods, such as weight loss, for people without celiac disease, many consumers are eating gluten-free foods "just for the variety," Harriman said.
    Either way, the market for gluten-free foods is set to approach $5 billion by 2021, up from $2.84 billion in 2014. Going forward, more of that market will go to gluten-free grains, lees to wheat.
    Flour used to be the main way consumers bought whole grains, but now consumers and manufacturers are embracing complete, minimally processed whole grains, which can improve product textures, flavors and health benefits.
    Sprouted grains are also receiving more attention and are expected to generate product sales of $250 million by 2018. Overall, 27% of consumers say they are eating more whole grains than they did six months ago, according to a recent survey.
    Read more at Fooddive.com.

    Jefferson Adams
    Celiac.com 03/22/2017 - A new study published in the journal Food Chemistry shows that even the ancient varieties of wheat that have not been subject to hybridization, contain toxic epitopes that trigger adverse autoimmune response in celiac patients.
    What makes gluten toxic to people with celiac disease? Also, what is the relationship between various kinds of wheat and their celiac toxicity?
    To answer those questions, a team of researchers analyzed various kinds of wheat from several countries, all produced in the same agronomic year (2013-2014) at the Experimental Station at the Agronomic, Food and Biosystems School of Madrid.
    Their study focused on a specific set of proteins in gluten, called gliadins. Marta Rodríguez-Quijano, a researcher at the Technical University of Madrid and one of the writers behind the study, says that "gliadins have the greatest clinical effect against the innate and adaptive immune responses that lead to coeliac disease." However, the specific type of gliadins differ among the many varieties of wheat.
    The scientists assessed the presence of T-lymphocytes (immune cells that are related to celiac disease) in the various kinds of wheat) by using an antibody capable of recognizing toxic epitopes or antigenic determinants. Their data shows that the different varieties of wheat produce considerably different immune responses depending on the T-cells analyzed.
    Certain wheat varieties, such as the French "Pernel' T. aestivum ssp. vulgare L., have low toxic epitope content," explains Rodríguez-Quijano, which means that they are less likely to trigger a strong immune reaction in people with celiac disease.
    This study provides the scientific basis for using such epitopes to design and breed wheat products that are safe for people with celiac disease. A successful effort in this arena will help to "combat the poor nutritional and technological characteristics of gluten-free products and thereby contribute to improving patients' quality of life," says Rodríguez-Quijano.
    This researchers are not alone in their efforts to create wheat strains that are safe for people with celiac disease. A similar project is under way in Kansas, with researchers working with the University and industry support to evaluate wheat strains that may be suitable for people with celiac disease.
    Will the future mean safe wheat for people with celiac disease? Stay tuned for developments on this and related stories.

    Jefferson Adams
    Celiac.com 06/01/2017 - With low prices and slim margins, life is tough for people who trade in wheat, corn and soybeans these days. So much so that some traders are turning to obscure commodities like desert-grown tomatoes and chickpeas to turn a profit.
    Over the last several years, as farmers have produced far more of these crops than the marker can handle, margins for handling major grain crops have sunk. That has led some trading firms to seek higher margins in niche markets, such as tomatoes and organic grains, while other firms are looking to organic grains, and markets for costlier processed food ingredients or gluten-free products.
    One such company is Germany's BayWa AG. According to Jean-Francois Lambert, the founder and managing partner of consultant Lambert Commodities, "The general trading environment for agricultural commodities is rather difficult," and the challenge looks to continue, at least through next year.
    This fall in prices is a far cry from the price surge seen for much of the previous decade, when growing populations and burgeoning economies drove rising demand.
    Now, really huge firms are unlikely to see much benefit from investing in these smaller markets, no matter the margins. That's because the markets are still too small to have any major impact on their bottom line, and any gains would represent only tiny fractions of their overall portfolios.
    However, small and mid-sized traders can potentially do much better with investments in lesser-known commodities like quinoa or organic crops. For these traders, higher margins and growing demand can yield returns that improve their bottom line. One small company, Grain Services Srl, a brokerage based in Reggio Emilia, Italy, currently receives about 30 percent of its total revenue from gluten-free, organic or niche products, including quinoa, rice, amaranth and lentils, even though these make up just 7% of the firms overall business, says managing director Andrea Cagnolati.
    With prices for gluten-free grains and flours expected to surge over the next ten years, look for more investors to make big bets on that market, or to use it as a hedge against major market doldrums.
    Source:
    ESMMagazine.com

    Jefferson Adams
    Celiac.com 10/03/2017 - As people eat less processed foods, and more people adopt a gluten-free diet, manufacturers are selling less and less refined wheat flour, less bread, rolls, and cereals.
    Consumption of wheat is plummeting, and that has the people who grow wheat wondering what to do.
    Well, one thing wheat growers can do is hire researchers to study the problem in such a way that the logical conclusion is that foods made from refined grains, such as breads, rolls, and cereals, aren’t really that bad after all.
    And that seems to be what happened with a recent study funded by the Grain Foods Foundation, an industry group.
    Unsurprisingly, perhaps, the study, published last month in the journal Nutrients, calls things like breads, rolls, tortillas, and ready-to-eat cereals "meaningful contributors" of nutrients like thiamin, folate, iron, zinc, and niacin.
    The study notes that such foods are also low in added sugars and fats, which is not the case with many grain foods like baked goods.
    Rather than being independent, both authors of the study work for PR companies that help other companies, including major food and beverage companies, communicate the benefits of their products.
    While it’s true that many refined grain foods provide these nutrients, there are many other sources.
    For example, foods like white beans, lentils, spinach, dark chocolate, and tofu provide iron, while oysters, beef, baked beans, yogurt, and chickpeas provide zinc.
    Is bread bad for people? Mostly not. People with celiac disease need to eat gluten-free, and should probably make an extra effort to eat foods that are nutrient dense. For most folks bread is fine, but as with many foods, not all breads are equal. Look for whole-grain breads that are nutrient dense. Watch out for the added sugar, salt, and fat that come with many processed foods.
    And don’t be swayed by industry-funded studies that tell you to eat more of the product they are peddling.
    Read more at: Healthline.com

  • Recent Articles

    Jefferson Adams
    Celiac.com 06/21/2018 - Would you buy a house advertised as ‘gluten-free’? Yes, there really is such a house for sale. 
    It seems a Phoenix realtor Mike D’Elena is hoping that his trendy claim will catch the eye of a buyer hungry to avoid gluten, or, at least one with a sense of humor. D’Elena said he crafted the ads as a way to “be funny and to draw attention.” The idea, D’Elena said, is to “make it memorable.” 
    Though D’Elena’s marketing seeks to capitalizes on the gluten-free trend, he knows Celiac disease is a serious health issue for some people. “[W]e’re not here to offend anybody….this is just something we're just trying to do to draw attention and do what's best for our clients," he said. 
    Still, the signs seem to be working. D'elena had fielded six offers within a few days of listing the west Phoenix home.
    "Buying can sometimes be the most stressful thing you do in your entire life so why not have some fun with it," he said. 
    What do you think? Clever? Funny?
    Read more at Arizonafamily.com.

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.